Russia plans to approve COVID vaccine still in trial

Updated: Jul 30, 2020, 09:40 IST | Agencies | Moscow

"Our scientists focused not on being the first but on protecting people," said Dmitriev. Alexander Ginsburg, the project director, told CNN that he has already taken the vaccine shot

A waitress serves a meal in a cafe in central Moscow. File pic/AFP
A waitress serves a meal in a cafe in central Moscow. File pic/AFP

Russia is rushing to win the race to develop a vaccine against the novel Coronavirus, and in the process has planned to approve by early August a vaccine that is still in the trial phase, according to a report in CNN.

The vaccine, being developed by Gamaleya Institute in Moscow, is likely to be approved for public use on August 10 and the frontline health workers will receive the shots first, the report said. "It's a Sputnik moment," CNN quoted said Kirill Dmitriev, head of Russia's sovereign wealth fund financing the vaccine research, as saying. He was referring to the successful launch of the world's first satellite by the Soviet Union in 1957.

"Americans were surprised when they heard Sputnik's beeping. It's the same with this vaccine. Russia will have got there first," he added. However, concerns have been raised about the vaccine, as Russia has not yet completed the second phase of the trial. The developers said they aim to complete the second phase by August 3, and will run the third trial along with the vaccination of the health workers.

"Our scientists focused not on being the first but on protecting people," said Dmitriev. Alexander Ginsburg, the project director, told CNN that he has already taken the vaccine shot.

10 Aug
The target date for the approval

Catch up on all the latest Crime, National, International and Hatke news here. Also download the new mid-day Android and iOS apps to get latest updates.

Mid-Day is now on Telegram. Click here to join our channel (@middayinfomedialtd) and stay updated with the latest news

This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever

Sign up for all the latest news, top galleries and trending videos from Mid-day.com

Subscribe
loading image
This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK